Nventa Biopharmaceuticals Corporation
Profile
Mailing Address: Nventa Biopharmaceuticals Corporation
5666 La Jolla Blvd. #319
La Jolla, California
92037
Head Office Address: Nventa Biopharmaceuticals Corporation
4370 La Jolla Village Drive
Suite 400
San Diego, California
92122-1249
Contact Name: Jovie Sabal-Diaz or Berenice Brownlee Principal Regulator: British Columbia
Business e-mail address: ir@nventacorp.com Short Form Prospectus Issuer: Yes
Telephone Number: 858 202-4900 Reporting Jurisdictions: British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, Quebec, Nova Scotia
Fax Number: 858 450-6849 Stock Exchange: TSX
Date of Formation: Jan 27 2006 Stock Symbol: NVN
Jurisdiction Where Formed: British Columbia Auditor: Deloitte & Touche LLP
Industry Classification: consumer products - biotechnology/pharmaceuticals General Partner:
CUSIP Number: 86330W Transfer Agent: Computershare Investor Services Inc.
Financial Year-End: Dec 31 Size of Issuer (Assets): $5,000,001 to $25,000,000


View This Company's Documents